Copyright
©The Author(s) 2022.
World J Methodol. Jul 20, 2022; 12(4): 246-257
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.246
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.246
Figure 2 Role of gut microbiota and short-chain fatty acids in the pathophysiology of diabetes mellitus.
SCFA: Short-chain fatty acids; GLP-1: Glucagon-like peptide-1; PYY: Peptide YY.
- Citation: Kant R, Chandra L, Verma V, Nain P, Bello D, Patel S, Ala S, Chandra R, Antony MA. Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus. World J Methodol 2022; 12(4): 246-257
- URL: https://www.wjgnet.com/2222-0682/full/v12/i4/246.htm
- DOI: https://dx.doi.org/10.5662/wjm.v12.i4.246